Capital Policy through Share Buybacks
First written in FY2016. 4 of 8 entries say "Advanced", first in FY2017-Q1. Latest entry: FY2025-H1.
- FY2025-H1AdvancedAnnual report
「Details of the purchase: (1) Class of shares acquired: common shares of the Company; (2) total number of shares acquired: 3,672,000 shares; (3) total acquisition price: ¥2,530 million; (4) acquisition date: 1 November 2024; (5) acquisition method: purchase through the Tokyo Stock Exchange’s off-auction purchase of treasury shares (ToSTNeT-3).」
On 1 November 2024, the Company acquired 3,672,000 treasury shares for a total of ¥2,530 million, moving into the execution phase of the treasury share acquisition. - FY2018RestatedAnnual report
「Resolution status at the Board of Directors meeting held on 21 September 2017 (acquisition period: 22 September 2017 to 22 September 2017): 940,000 shares, ¥2,885,800,000. Treasury shares acquired during the fiscal year: 854,100 shares, ¥2,622,087,000. Total number and aggregate value of shares remaining under the resolution: 85,900 shares, ¥263,713,000.」
Regarding the acquisition of treasury shares to address the disposal of shares held by the GSK Group and to return profits to shareholders, the Company acquired 854,100 shares for ¥2,622 million, leaving 85,900 shares under the resolution. - FY2018-Q2AdvancedAnnual report
「Reason for acquiring treasury shares: to prepare for the disposal of shares held by the GlaxoSmithKline Group following the revision of the comprehensive agreement with the group, and to return profits to the Company’s shareholders. Total number of shares acquired: 854,100 shares. Total acquisition price: ¥2,622 million. Acquisition date: 22 September 2017. Acquisition method: purchase through the Tokyo Stock Exchange’s off-auction purchase of treasury shares (ToSTNeT-3).」
After completing the previous treasury share acquisition program, the Company acquired 854,100 shares for ¥2,622 million to address the disposal of shares held by the GSK Group and to return profits to shareholders. - FY2017AchievedAnnual report
「Resolution status at the Board of Directors meeting held on 26 February 2016 (acquisition period: 29 February 2016 to 31 August 2016): 400,000 shares, ¥1,000,000,000. Treasury shares acquired during the fiscal year: 267,500 shares, ¥776,320,955. Total number and aggregate value of shares remaining under the resolution: none.」
The treasury share acquisition plan was completed, with no shares remaining under the resolution after including the acquisitions made during the fiscal year. - FY2017-Q3RestatedAnnual report
「As of the end of the third quarter of the current consolidated fiscal year, the balance of treasury shares had increased by ¥731.666 million from the end of the previous consolidated fiscal year to ¥1,513.281 million. This was mainly due to the acquisition of 267,500 shares for ¥776.320 million pursuant to a resolution of the Board of Directors dated 26 February 2016.」
The acquisition of 267,500 treasury shares for ¥776.320 million pursuant to the Board of Directors’ resolution was reconfirmed. No new acquisition resolution or additional acquisition was disclosed. - FY2017-Q2AdvancedAnnual report
「As of the end of the second quarter of the current consolidated fiscal year, the balance of treasury shares had increased by ¥735.098 million from the end of the previous consolidated fiscal year to ¥1,516.713 million. This was mainly due to the acquisition of 267,500 shares for ¥776.320 million pursuant to a resolution of the Board of Directors dated 26 February 2016.」
Regarding the acquisition of treasury shares, the Company disclosed that it acquired 267,500 shares for ¥776.320 million pursuant to a resolution of the Board of Directors. - FY2017-Q1AdvancedAnnual report
「Net assets decreased ¥639 million from the end of the previous consolidated fiscal year to ¥26,422 million, as the company recorded quarterly net income but paid dividends and acquired treasury shares for ¥476 million, among other factors.」
Regarding the acquisition of treasury shares, the Company reports that it acquired shares worth ¥476 million during the cumulative period through the current quarter. - FY2016First statedAnnual report
「Status of the resolution by the Board of Directors (resolution dated 26 February 2016; acquisition period: 29 February 2016 to 31 August 2016): 400,000 shares, ¥1,000,000,000」
Based on the Board of Directors' resolution of 26 February 2016, the company is conducting a share buyback of up to 400,000 shares and ¥1 billion during the specified acquisition period.